Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 73-82 , 25 January 2010

Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus

  • S. Williams

      Affiliations

    • Neuroimmunology Labs, School of Life Sciences, Arizona State University, Tempe, AZ, 85287-4501 USA
    • ,
  • B. Sakic

      Affiliations

    • Department of Psychiatry & Behavioral Neuroscience, McMaster University, Hamilton, ON, Canada, L8N3Z5
    • ,
  • S.A. Hoffman

      Affiliations

    • Neuroimmunology Labs, School of Life Sciences, Arizona State University, Tempe, AZ, 85287-4501 USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 480 965 7024; fax: +1 480 965 6899.

Received 13 May 2009 ,Revised 16 September 2009 ,Accepted 13 October 2009.

References 

  1. Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus. 2003;12:908–915
  2. Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ. Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur. J. Immunol. 2007;37:1691–1701
  3. Aotsuka S, Okawa M, Ikebe K, Yokohari R. Measurement of anti-double stranded DNA antibodies in major immunoglobulin classes. J. Immunol. Methods. 1979;28:149–162
  4. Ballok DA, Millward JM, Sakic B. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res. 2003;964:200–210
  5. Ballok DA, Szechtman H, Sakic B. Taste responsiveness and diet preference in autoimmune MRL mice. Behav. Brain Res. 2003;140:119–130
  6. Ballok DA, Woulfe J, Sur M, Cyr M, Sakic B. Hippocampal damage in mouse and human forms of systemic autoimmune disease. Hippocampus. 2004;14:649–661
  7. Ballok DA, Ma X, Denburg JA, Arsenault L, Sakic B. Ibuprofen fails to prevent brain pathology in a model of neuropsychiatric lupus. J. Rheumatol. 2006;33:2199–2213
  8. Bartholomew SA, Hoffman SA. Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse. Brain Behav. Immun. 1993;7:301–316
  9. Bindoni M, Perciavalle V, Berretta S, Belluardo N, Diamantstein T. Interleukin-2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus. Brain Res. 1988;462:10–14
  10. Bluestein HG, Zvaifler NJ. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 1976;57:509–516
  11. Bluestein HG, Williams GW, Steinberg AD. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 1981;70:240–246
  12. Carr RI, Shucard DW, Hoffman SA, Hoffman AW, Bardana EJ, Harbeck RJ. Neuropsychiatric involvement in systemic lupus erythematosus. Birth Defects Orig. Artic. Ser. 1978;14:209–235
  13. Crimando J, Hoffman SA. Characterization of murine brain-reactive monoclonal IgG autoantibodies. Brain Behav. Immun. 1995;9:165–181
  14. Dunn AJ. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. 1988;43:429–435
  15. Fessel WJ. Autoimmunity and mental illness. A preliminary report. Arch. Gen. Psychiatry. 1962;6:320–323
  16. Fessel WJ. Macroglobin elevations in functional mental illness. Nature. 1962;193:1005
  17. Fessel WJ. Blood proteins in functional psychoses. A review of the literature and unifying hypothesis. Arch. Gen. Psychiatry. 1962;6:132–148
  18. Fessel WJ, Hirata-Hibi M. Abnormal leucocytes in schizophrenia. Arch. Gen. Psychiatry. 1963;106:601–613
  19. Ganguli R, Brar JS, Chengappa KN, Yang ZW, Nimgaonkar VL, Rabin BS. Autoimmunity in schizophrenia: a review of recent findings. Ann. Med. 1993;25:489–496
  20. Gitlits VM, Sentry JW, Matthew ML, Smith AI, Toh BH. Synapsin I identified as a novel brain-specific autoantigen. J. Investig. Med. 2001;49:283
  21. Hanly JG. Neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 2005;31:273–298vi
  22. Harbeck RJ, Hoffman AA, Hoffman SA, Shucard DW, Carr RI. A naturally occurring antibody in New Zealand mice cytotoxic to dissociated cerebellar cells. Clin. Exp. Immunol. 1978;31:313–320
  23. Harbeck RJ, Hoffman AA, Hoffman SA, Shucard DW. Cerebrospinal fluid and the choroid plexus during acute immune complex disease. Clin. Immunol. Immunopathol. 1979;13:413–425
  24. Hess DC, Taormina M, Thompson J, Sethi KD, Diamond B, Rao R, et al. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J. Rheumatol. 1993;20:610–617
  25. Hoffman SA, Harbeck RJ. CNS lupus and the blood-brain barrier. In:  Neuwelt EA editors. Implications of the Blood-Brain Barrier and Its Manipulation. New York-London: Plenum Medical Book Co; 1989;p. 469–494
  26. Hoffman SA, Madsen CS. Brain specific autoantibodies in murine models of systemic lupus erythematosus. J. Neuroimmunol. 1990;30:229–237
  27. Hoffman SA, Sakic B. The neuroimmunological basis of behavior and mental disorders. In:  Siegel A,  Zalcman SS editor. Ref Type: Serial (Book, Monograph). New York, NY: Springer; 2009;p. 341–381
  28. Hoffman SA, Hoffman AA, Shucard DW, Harbeck RJ. Antibodies to dissociated cerebellar cells in New Zealand mice as demonstrated by immunofluorescence. Brain Res. 1978;142:477–486
  29. Hoffman SA, Shucard DW, Harbeck RJ, Hoffman AA. Chronic immune complex disease: behavioral and immunological correlates. J. Neuropathol. Exp. Neurol. 1978;37:426–436
  30. Hoffman SA, Shucard DW, Brodie HA, Reifenrath C, Harbeck RJ. Suppression of water intake by immune complex formation in the hypothalamus. Implications for systemic lupus erythematosus. J. Neuroimmunol. 1982;2:167–176
  31. Hoffman SA, Arbogast DN, Day TT, Shucard DW, Harbeck RJ. Permeability of the blood cerebrospinal fluid barrier during acute immune complex disease. J. Immunol. 1983;130:1695–1698
  32. Hoffman SA, Arbogast DN, Ford PM, Shucard DW, Harbeck RJ. Brain-reactive autoantibody levels in the sera of ageing autoimmune mice. Clin. Exp. Immunol. 1987;70:74–83
  33. Hoffman SA, Ford P, Kubo R. Characterization of cell surface antigens on the adrenergic neuroblastoma clone A2(1). Brain Res. 1988;452:358–366
  34. Hoffman SA, Shucard DW, Harbeck RJ. The immune system can affect learning: chronic immune complex disease in a rat model. J. Neuroimmunol. 1998;86:163–170
  35. James WG, Hutchinson P, Bullard DC, Hickey MJ. Cerebral leucocyte infiltration in lupus-prone MRL/MpJ-fas lpr mice-roles of intercellular adhesion molecule-1 and P-selectin. Clin. Exp. Immunol. 2006;144:299–308
  36. Khin NA, Hoffman SA. Brain reactive monoclonal auto-antibodies: production and characterization. J. Neuroimmunol. 1993;44:137–148
  37. Kim YK, Lee MS, Suh KY. Decreased interleukin-2 production in Korean schizophrenic patients. Biol. Psychiatry. 1998;43:701–704
  38. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity; antibody impairs memory. Immunity. 2004;21:179–188
  39. Kowal C, DeGiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 2006;103:19854–19859
  40. Lawrence DA, Bolivar VJ, Hudson CA, Mondal TK, Pabello NG. Antibody induction of lupus-like neuropsychiatric manifestations. J. Neuroimmunol. 2007;182:185–194
  41. Lehmann-Facius H. Serologisch-analytische Versuche mit Liquores und Seren von Schizophrenen. Allg. Z. Psychiatrie. 1939;110:232–243
  42. Ma, X., Foster, J., Sakic, B., 2006. Distribution and prevalence of leukocyte phenotypes in brains of lupus-prone mice. J. Neuroimmunol.
  43. Margutti P, Delunardo F, Ortona E. Autoantibodies associated with psychiatric disorders. Curr. Neurovasc. Res. 2006;3:149–157
  44. Martin SE, Martin WJ. Expression by human neuroblastoma cells of an antigen recognized by naturally occurring mouse anti-brain autoantibody. Cancer Res. 1975;35:2609–2612
  45. Mondal TK, Saha SK, Miller VM, Seegal RF, Lawrence DA. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model. Brain Behav. Immun. 2008;22:949–959
  46. Narendran A, Hoffman SA. Identification of autoantibody reactive integral brain membrane antigens — a two dimensional analysis. J. Immunol. Methods. 1988;114:227–234
  47. Narendran A, Hoffman SA. Characterization of brain-reactive autoantibodies in murine models of systemic lupus erythematosus. J. Neuroimmunol. 1989;24:113–123
  48. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977;229:327–336
  49. Sakic B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav. Immun. 1992;6:265–285
  50. Sakic B, Szechtman H, Denburg SD, Carbotte RM, Denburg JA. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiol. Behav. 1993;54:1025–1029
  51. Sakic B, Szechtman H, Denburg SD, Carbotte RM, Denburg JA. Spatial learning during the course of autoimmune disease in MRL mice. Behav. Brain Res. 1993;54:57–66
  52. Sakic B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol. Behav. 1994;56:609–617
  53. Sakic B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. Behaviour and immune status of MRL mice in the postweaning period. Brain Behav. Immun. 1994;8:1–13
  54. Sakic B, Denburg JA, Denburg SD, Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res. Bull. 1996;41:305–311
  55. Sakic B, Szechtman H, Braciak TA, Richards CD, Gauldie J, Denburg JA. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res. Bull. 1997;44:155–165
  56. Sakic B, Szechtman H, Denburg JA. Neurobehavioral alteration in autoimmune mice. Neurosci. Biobehav. Rev. 1997;21:327–340
  57. Sakic B, Szechtman H, Denburg JA, Gorny G, Kolb B, Whishaw IQ. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 1998;87:162–170
  58. Sakic B, Maric I, Koeberle PD, Millward JM, Szechtman H, Maric D, et al. Increased TUNEL-staining in brains of autoimmune Fas-deficient mice. J. Neuroimmunol. 2000;104:147–154
  59. Sakic B, Hanna SE, Millward JM. Behavioral heterogeneity in an animal model of neuropsychiatric lupus. Biol. Psychiatry. 2005;57:679–687
  60. Sakic B, Kirkham DL, Ballok DA, Mwanjewe J, Fearon IM, Macri J, et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J. Neuroimmunol. 2005;169:68–85
  61. Schott K, Schaefer JE, Richartz E, Batra A, Eusterschulte B, Klein R, et al. Autoantibodies to serotonin in serum of patients with psychiatric disorders. Psychiatry Res. 2003;121:51–57
  62. Schupf N, Williams CA. Psychopharmacological activity of immune complexes in rat brain is complement dependent. J. Neuroimmunol. 1987;13:293–303
  63. Sidor MM, Sakic B, Malinowski PM, Ballok DA, Oleschuk CJ, Macri J. Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice. J. Neuroimmunol. 2005;165:104–113
  64. Solomon GF, Moos RH, Fessel WJ, Morgan EE. Globulins and behavior in schizophrenia. Int. J. Neuropsychiatry. 1966;2:20–26
  65. Solomon GF, Allansmith M, McCellan B, Amkraut A. Immunoglobulins in psychiatric patients. Arch. Gen. Psychiatry. 1969;20:272–277
  66. Szechtman H, Sakic B, Denburg JA. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease. Lupus. 1997;6:223–229
  67. Tanaka S, Matsunaga H, Kimura M, Tatsumi K, Hidaka Y, Takano T, et al. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol. 2003;141:155–164
  68. Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, et al. Age-associated increase in interleukin 6 in MRL/lpr mice. Int. Immunol. 1991;3:273–278
  69. Theofilopoulos AN. Murine models of lupus. In:  Lahita RG editors. Systemic Lupus Erythematosus. New York: Churchill Livingstone; 1992;p. 121–194
  70. Vogelweid CM, Johnson GC, Besch-Williford CL, Basler J, Walker SE. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J. Neuroimmunol. 1991;35:89–99
  71. West SG. Lupus and the central nervous system. Curr. Opin. Rheumatol. 1996;8:408–414
  72. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 1992;16:525–534
  73. Zalcman S, Greenjohnson JM, Murray L, Nance DM, Dyck D, Anisman H, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994;643:40–49
  74. Zameer A, Hoffman SA. Immunoglobulin binding to brain in autoimmune mice. J. Neuroimmunol. 2001;120:10–18
  75. Zameer A, Hoffman SA. Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice. J Neuroimmunol. 2003;142:67–74
  76. Zameer A, Hoffman SA. B and T cells in the brains of autoimmune mice. J. Neuroimmunol. 2004;146:133–139
  77. Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 2007;36:297–315

PII: S0165-5728(09)00400-7

doi: 10.1016/j.jneuroim.2009.10.008

Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 73-82 , 25 January 2010

Article Tools

* Image Usage & Resolution